Conducted pre-acquisition FCPA due diligence for a manufacturing company, with a particular focus on third-party risks in China.
Represented a public company CEO in a grand jury investigation in the Eastern District of Virginia involving allegations of public corruption, securities
laws violations, and bank fraud, and in a related civil action.
Represented a financial institution in a grand jury investigation in the Western District of Virginia involving allegations of fraud related to the
implementation of the Home Affordable Modification Program (HAMP), resulting in a non-criminal resolution.
Represented a pharmaceutical company in connection with FCPA internal investigations and voluntary disclosures to DOJ and the SEC, resulting in FCPA
resolutions that commended the level of cooperation and efforts to enhance compliance.
Defended an indicted banker in the Eastern District of Virginia in connection with an alleged conspiracy to evade federal income taxes.
Performed post-acquisition FCPA due diligence in China, Russia, and several European countries for a pharmaceutical company.
Represented a chemical company in connection with a SEC investigation into bribery allegations related to operations and joint ventures in the Middle
Conducted an internal investigation on behalf of the audit committee of a global IT services firm in connection with a SEC investigation of accounting
errors and public misstatements.